Doyle, C. (2016). Immunotherapy with Blinatumomab Prolongs Survival in Acute Lymphoblastic Leukemia. Am Health Drug Benefits.
Chicago-стиль цитированияDoyle, Chase. "Immunotherapy With Blinatumomab Prolongs Survival in Acute Lymphoblastic Leukemia." Am Health Drug Benefits 2016.
MLA-цитированиеDoyle, Chase. "Immunotherapy With Blinatumomab Prolongs Survival in Acute Lymphoblastic Leukemia." Am Health Drug Benefits 2016.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.